Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Athira Pharma's Pre-Tax Income for the
three
months ended in Dec. 2024 was $-15.00 Mil. Athira Pharma's Revenue for the
three
months ended in Dec. 2024 was $0.00 Mil. Therefore, Athira Pharma's pretax margin for the quarter that ended in Dec. 2024 was %.
The historical rank and industry rank for Athira Pharma's Pretax Margin % or its related term are showing as below:
ATHA's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -130.305 * Ranked among companies with meaningful Pretax Margin % only.
Athira Pharma Pretax Margin % Historical Data
The historical data trend for Athira Pharma's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Athira Pharma's Pretax Margin %
For the Biotechnology subindustry, Athira Pharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Athira Pharma's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Athira Pharma's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Athira Pharma's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Athira Pharma Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Athira Pharma's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ATHA has been successfully added to your 